The U.S. Department of Justice’s Drug Enforcement Administration (DEA) has officially made the move to reclassify cannabis from a Schedule I to a Schedule III drug under the Controlled Substances
On April 23, 2024, the Federal Trade Commission issued its final rule prohibiting employers from engaging in non-compete agreements with their employees. Passed by a 3-2 vote, the Commission anticipates
On March 20, 2024, a coalition of 21 state attorneys general sent a letter to Congress advocating for federal clarification on the definition of hemp, and an end to what
Kentucky residents are one step closer to being able to purchase medical marijuana products. Implementation of the state’s medical cannabis program has begun with an eye on sales beginning in